CLINICAL study SHOWS DETECTION OF CTCs in glioblastoma Patients GBM CTC isolation only possible with Parsortix label-free ...

Our value-based model works to ensure that post-acute patients receive the right level of care, in the right setting, at the right time. By bringing together centralized oversight, clinical expertise, ...

The 2025 ASTRO annual meeting featured a prostate cancer session and a presentation by Dr. Angela Jia discussing the clinical ...

It is important to empower patients to receive immunizations and address concerns amid changes to the CDC’s advisory ...

Already approved for progressive multiple sclerosis, ocrelizumab in a second phase 3 study demonstrates meaningful clinical ...

Genmab acquires Merus for $8bn, adding promising oncology asset petosemtamab. Check out my thoughts on this deal and my ...

Background Although surgical gastrojejunostomy (SGJ) is the standard method for palliation of gastric outlet obstruction (GOO ...

In 2023, 36,500 Connecticut residents were hospitalized after falls, and 411 - mostly older adults - died, according to state ...

In addition to discussing third quarter 2025 financial results, the Investor Day will feature: An in-depth look into the Company’s strategy for long-term, sustained growth for ZORYVE® (roflumilast) ...

GE HealthCare gets downgraded slightly to a hold from my prior buy rating last fall, agreeing with Seeking Alpha's quant ...